Меню
КартаВръзкиТемиБългарияНощта (K-TRIO)Мария Склодовска-КюриЗа ученициЗа учителиМетодологияИзненадай ме
HEСъфинансиране2023–2028

CarrerasLeaders · Carreras Postdoc Program Empowering Future Leaders to Fight Blood Cancers

„Хоризонт Европа“ — Действия „Мария Склодовска-Кюри“

Период
2023-01-01 → 2028-12-31
Финансиране от ЕС
2 292 480 €
Участници
46
Схема
HORIZON-TMA-MSCA-Cofund-P

Линиите свързват координатора с партньорите.

Накратко на български

Ракът на кръвта, като левкемията и лимфома, се изучава от биологичните му механизми до създаването на нови диагностични инструменти и терапии. Това помага фундаменталните научни открития да се превърнат в реални методи за лечение на пациентите.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Carreras Postdoc Program Empowering Future Leaders to Fight Blood Cancers

The CarrerasLeaders program is an international postdoctoral initiative led by the Josep Carreras Leukaemia Research Institute (IJC), a non-profit biomedical research center specializing in leukemia and other blood cancers. This program addresses a critical need for advanced research training in hematological malignancies by funding a total of 16 outstanding postdoctoral researchers over a three-year period. In its initial phase, 10 researchers were selected through a rigorous evaluation process, with additional rounds planned to reach the full target. The objective is to equip these researchers with the expertise, networks, and innovative skills required to translate cutting-edge discoveries into effective clinical applications. Despite significant advances in understanding blood cancers, major gaps persist in converting fundamental discoveries into effective treatments. CarrerasLeaders bridges these gaps by fostering interdisciplinary research, promoting early scientific advances, and strengthening career development. The program covers the full research and innovation cycle - from deciphering disease biology to developing novel treatments, diagnostic tools, and clinical applications- with a global translational approach that ensures leukemia and lymphoma research has a direct real-world impact. Key broader objectives include: - Enhancing the quality and focus of postdoctoral research training in blood cancers to address pressing societal needs. - Promoting cross-sector and interdisciplinary knowledge transfer. - Empowering emerging researchers to advance their careers within a world-class institution. - Increasing the competitiveness and global reputation of the IJC blood cancers community.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

CarrerasLeaders is a new innovative and international postdoctoral programme, designed by Josep Carreras Leukaemia Research Institute (IJC), an independent, non-profit biomedical research institute that is part of the Government of Catalonia network of Research Centres (CERCA). IJC is the first European institute exclusively devoted to leukaemia and other malignant blood diseases. The aim of the programme is to fund 16 excellent postdoctoral researchers for a period of 36 months. The selection of the fellows is merit-based, founded on peer review in an open and transparent selection procedure. Carrerasleaders is addressed to boost career perspective of researchers from a three-dimensional perspective: leadership, independence, and consolidation.This is a world-wide unique postdoctoral program that covers the entire spectrum of research and innovation in blood cancers and goes from understanding disease biology to the implementation of products and processes in the market and into the clinical practice through the development of a global translational approach. Applicants will have complete freedom of research choice within the scope of blood cancers and will be offer highly attractive working conditions and a healthy, inspiring and creative working environment. CarrerasLeaders is designed based on the following objectives: 1. Training the next generation of scientist leaders to advance on the cure of blood cancers, multiplying each one’s skills sets and networks via targeted Career Development Plans and mentoring.2.Improve the quality of blood cancers postdoctoral research training, more targeted addressed to the researchers and societal needs. 3.Enhanced cooperation and transfer knowledge between sectors and disciplines.4.Enable outstanding junior researchers to develop their research careers to an advanced and more independent level in a leading institution such as IJC. 5.Increase the competitiveness of the IJC blood cancers community

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз